Understanding when and how physicians dispense product samples
Because physicians' use of product samples varies across pharmaceutical classes and products in measurable ways, it behooves drug companies to start assessing how much their sampling is actually boosting market share and how much it is simply cutting their revenue-generating prescriptions.
You may also be interested in...
What percentage of samples dispensed support their major purpose--encouraging new courses of prescription therapy? The unsettling answer: far more than most people think.
Phase I data presented at ASCO for ALLO-501 offer proof of concept for the CD19 allogeneic CAR-T and a companion drug, ALLO-647, for lymphodepletion.